TruNorth Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$468K Buy
1,768
+266
+18% +$70.2K 0.07% 73
2026
Q2
$381K Hold
1,502
– – 0.06% 78
2026
Q1
$367K Buy
1,502
+114
+8% +$26.6K 0.07% 69
2025
Q4
$287K Buy
1,388
+119
+9% +$23.5K 0.05% 87
2025
Q3
$235K Buy
1,269
+385
+44% +$66K 0.05% 84
2025
Q2
$135K Sell
884
-776
-47% -$119K 0.03% 100
2025
Q1
$275K Buy
1,660
+776
+88% +$121K 0.07% 82
2024
Q4
$128K Hold
884
– – 0.03% 91
2024
Q3
$143K Buy
884
+20
+2% +$3.19K 0.04% 78
2024
Q2
$126K Buy
864
+215
+33% +$32K 0.04% 77
2024
Q1
$103K Buy
+649
New +$103K 0.04% 78

Other funds holding JNJ

TruNorth Capital Management's JNJ Position: Q3 2026 in Review

TruNorth Capital Management increased its Johnson & Johnson (JNJ) stake by 18% in Q3 2026, buying an estimated $70.2K and bringing the position to 1,768 shares worth $468K. The position accounts for 0.07% of the portfolio, ranked #73.

TruNorth Capital Management first reported a position in JNJ in Q1 2024 and has held it in 11 quarters since. 750 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • TruNorth Capital Management held 1,768 shares of Johnson & Johnson worth $468K as of Q3 2026.
  • TruNorth Capital Management bought 266 Johnson & Johnson shares in Q3 2026, an estimated $70.2K.
  • Johnson & Johnson made up 0.07% of TruNorth Capital Management's portfolio in Q3 2026, its #73 holding.
  • TruNorth Capital Management first reported a position in Johnson & Johnson in Q1 2024 and has held it in 11 quarters since.
  • 750 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on TruNorth Capital Management's 13F filing for Q3 2026, filed 14 Oct 2026.